|
|||||
|
|
Modified CVAD and modified CBAD compared to high‐dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma |
|
| Authors: | Suzanne C. Gettys Alison Gulbis Kaci Wilhelm Koji Sasaki Yvonne Dinh Gabriela Rondon Muzaffar H. Qazilbash |
| Affiliation: | 1. Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. McKesson Corporation, Santa Barbara, CA, USA;3. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| Abstract: | |
| Keywords: | autologous bortezomib cyclophosphamide mobilization multiple myeloma |